Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F8ZYY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,536
Award facts
- Contract value 100% obligated
- $13,535.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $13,535.62. This is a competitive, non-set-aside award issued as a child delivery order, with performance to be completed by November 21, 2025, at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a JAK inhibitor used primarily for the treatment of rheumatoid arthritis and other inflammatory conditions, representing a specialty pharmaceutical product typical of the Defense Logistics Agency's medical supply procurement.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical devices to support military healthcare programs and federal medical systems worldwide. The firm's track record of competitive awards and delivery order fulfillment demonstrates its established capability to meet the Defense Logistics Agency's rigorous pharmaceutical procurement requirements.
Quick answers
Who was awarded contract SPE2DR26F8ZYY?
SPE2DR26F8ZYY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F8ZYY worth?
The government has obligated $13,536 on SPE2DR26F8ZYY.
Is contract SPE2DR26F8ZYY an order under another contract?
Yes. SPE2DR26F8ZYY is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F8ZYY competed?
The extent of competition for SPE2DR26F8ZYY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award